Apertura – Grupo 2
| Pos | equipo | PTS | PJ | G | E | P | GF | GC | DG | TA | TR | %GF | %GC | Racha | Últimos | Prox |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |  Canal de Isabel II | 18 | 8 | 6 | 0 | 2 | 27 | 11 | 16 | 3 | 2 | 3.38 | 1.38 | V1 |  | |
| 2 |  EY Consulting | 18 | 8 | 6 | 0 | 2 | 27 | 21 | 6 | 1 | 0 | 3.38 | 2.63 | D2 |  | |
| 3 |  Monitor Deloitte | 16 | 8 | 5 | 1 | 2 | 23 | 21 | 2 | 4 | 0 | 2.88 | 2.63 | V1 | | |
| 4 | EY Data | 15 | 8 | 5 | 0 | 3 | 23 | 16 | 7 | 6 | 0 | 2.88 | 2.00 | V1 |  | |
| 5 |  Valcor Consultores | 13 | 8 | 4 | 1 | 3 | 27 | 20 | 7 | 5 | 0 | 3.38 | 2.50 | V2 |  | |
| 6 |  Accenture World | 11 | 8 | 3 | 2 | 3 | 17 | 19 | -2 | 3 | 1 | 2.13 | 2.38 | E1 |  | |
| 7 |  McKinsey A | 7 | 8 | 2 | 1 | 5 | 15 | 18 | -3 | 1 | 0 | 1.88 | 2.25 | V1 |  | |
| 8 |  Abante Asesores | 4 | 8 | 1 | 1 | 6 | 8 | 22 | -14 | 3 | 0 | 1.00 | 2.75 | E1 |  | |
| 9 |  Insud Pharma | 3 | 8 | 1 | 0 | 7 | 14 | 33 | -19 | 5 | 0 | 1.75 | 4.13 | D4 |  |
Champions – Grupo 8
| Pos | equipo | PTS | PJ | G | E | P | GF | GC | DG | TA | TR | %GF | %GC | Racha |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Valcor Consultores | 6 | 2 | 2 | 0 | 0 | 8 | 4 | 4 | 0 | 0 | 4.00 | 2.00 | V2 |
| 2 |  Accenture Data | 3 | 2 | 1 | 0 | 1 | 4 | 6 | -2 | 0 | 0 | 2.00 | 3.00 | D1 |
| 3 |  Qaracter | 0 | 1 | 0 | 0 | 1 | 3 | 4 | -1 | 0 | 0 | 3.00 | 4.00 | D1 |
| 4 | Deloitte TS | 0 | 1 | 0 | 0 | 1 | 2 | 3 | -1 | 0 | 0 | 2.00 | 3.00 | D1 |
